WallStSmart

C3 Ai Inc (AI)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

C3 Ai Inc generates 19% more annual revenue ($307.39M vs $258.90M). ZEPP leads profitability with a -15.5% profit margin vs -141.3%. ZEPP earns a higher WallStSmart Score of 38/100 (F).

AI

Avoid

27

out of 100

Grade: F

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.8
Piotroski: 3/9Altman Z: 1.04

ZEPP

Hold

38

out of 100

Grade: F

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

AIUndervalued (+34.0%)

Margin of Safety

+34.0%

Fair Value

$16.42

Current Price

$9.60

$6.82 discount

UndervaluedFair: $16.42Overvalued
ZEPPUndervalued (+48.9%)

Margin of Safety

+48.9%

Fair Value

$46.96

Current Price

$18.01

$28.95 discount

UndervaluedFair: $46.96Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AI1 strengths · Avg: 8.0/10
Price/BookValuation
1.9x8/10

Reasonable price relative to book value

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

AI4 concerns · Avg: 3.0/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$1.33B3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Return on EquityProfitability
-55.0%2/10

ROE of -55.0% — below average capital efficiency

ZEPP4 concerns · Avg: 2.3/10
Market CapQuality
$270.28M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Free Cash FlowQuality
$-26.48M2/10

Negative free cash flow — burning cash

Comparative Analysis Report

WallStSmart Research

Bull Case : AI

The strongest argument for AI centers on Price/Book.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : AI

The primary concerns for AI are EPS Growth, Market Cap, Piotroski F-Score.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

AI profiles as a turnaround stock while ZEPP is a hypergrowth play — different risk/reward profiles.

AI carries more volatility with a beta of 1.99 — expect wider price swings.

ZEPP is growing revenue faster at 43.0% — sustainability is the question.

ZEPP generates stronger free cash flow (-26M), providing more financial flexibility.

Bottom Line

ZEPP scores higher overall (38/100 vs 27/100) and 43.0% revenue growth. AI offers better value entry with a 34.0% margin of safety. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

C3 Ai Inc

TECHNOLOGY · SOFTWARE - INFRASTRUCTURE · USA

C3.

Visit Website →

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?